基于人群的开角型青光眼患者视野进展可耐受速率研究
该研究基于塞萨洛尼基眼研究(Thessaloniki Eye Study)的开角型青光眼(OAG)人群数据,计算避免视觉损害(maxTRoP_VI)和失明(maxTRoP_BL)的最大可耐受视野进展速率。在123例有可靠视野的OAG受试者中,69.1%的maxTRoP_VI慢于-1dB/年,72.4%的maxTRoP_BL慢于-2dB/年;对于所有测试的视觉损害阈值,约86%的受试者无法耐受等于或快于-2dB/年的进展速率。作者认为多数患者较好眼的最大可耐受进展速率慢于-1dB/年,个体化视野监测策略重要但需考虑所需视野检查次数的可行性。
要点
- 在123例OAG受试者中,69.1%的maxTRoP_VI慢于-1dB/年,18.7%的maxTRoP_VI在-1至-2dB/年之间。
- 72.4%的受试者maxTRoP_BL慢于-2dB/年;所有测试阈值下约86%无法耐受等于或快于-2dB/年的进展。
- 多数患者较好眼的最大可耐受进展速率慢于-1dB/年,个体化视野监测需考虑检查次数可行性。
核心结论
- 本研究中多数青光眼患者较好眼的最大可耐受进展速率慢于-1dB/年。
- 个体化视野监测策略重要,但需考虑所需视野检查次数的可行性。
研究设计与样本
- 塞萨洛尼基眼研究(Thessaloniki Eye Study)为横断面、基于人群的欧洲人群研究,纳入OAG受试者进行分析。
- 视觉损害定义为平均偏差(MD)等于或差于-12dB,失明定义为MD等于或差于-24dB,并测试了其他视觉损害阈值。
- 对每例OAG受试者,使用年龄、性别、MD和预期寿命数据计算maxTRoP_VI和maxTRoP_BL,分析纳入每例MD较好的眼。
主要发现
- 135例OAG受试者中123例有可靠视野并纳入分析,平均年龄73±6岁,MD中位数-3.65±5.28dB。
- 69.1%的受试者maxTRoP_VI慢于-1dB/年,18.7%的maxTRoP_VI在-1至-2dB/年之间。
- 72.4%的受试者maxTRoP_BL慢于-2dB/年。
- 对于所有测试的视觉损害阈值,约86%的OAG研究受试者无法耐受等于或快于-2dB/年的进展速率。
关键数值与推荐
- 视觉损害阈值:MD等于或差于-12dB;失明阈值:MD等于或差于-24dB;原文另测试了其他视觉损害阈值但未列出具体数值。
- maxTRoP_VI定义为在预期寿命内不致视觉损害的进展速率,maxTRoP_BL定义相应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To provide population-based data on the maximum tolerable rate of progression to avoid visual impairment (maxTRoP_VI) and blindness (maxTRoP_BL) from open-angle glaucoma (OAG). METHODS: Participants with OAG in the Thessaloniki Eye Study (cross-sectional, population-based study in a European population) were included in the analysis. Visual impairment was defined as mean deviation (MD) equal to or worse than -12dB and blindness as MD equal to or worse than -24dB. Additional thresholds for visual impairment were tested. For each participant maxTRoP_VI was defined as the rate of progression which would not lead to visual impairment during expected lifetime. MaxTRoP_BL was defined accordingly. Both parameters were calculated for each OAG subject using age, sex, MD and life expectancy data. The eye with the better MD per subject was included in the analysis. RESULTS: Among 135 subjects with OAG, 123 had reliable visual fields and were included in the analysis. The mean age was 73±6 years and the median MD was -3.65±5.28dB. Among those, 69.1% would have a maxTRoP_VI slower than -1dB/year and 18.7% would have a maxTRoP_VI between -1 and -2dB/year. Also, 72.4% would have a maxTRoP_BL slower than -2dB/year. For all tested thresholds for visual impairment, approximately 86% of the OAG study participants would not be able to tolerate a rate of progression equal to or faster than -2dB/year. CONCLUSIONS: The majority of patients with glaucoma in our study would have a maximum tolerable rate of progression slower than -1dB/year in their better eye. Patient-tailored strategies to monitor the visual field are important, but raise the issue of feasibility with regard to the number of visual field tests needed.
引用
- Salonikiou A, Founti P, Kilintzis V, et al. Tolerable rates of visual field progression in a population-based sample of patients with glaucoma. Br J Ophthalmol. 2017. PMID: 28972029. doi:10.1136/bjophthalmol-2017-310635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。